CEO, CTO Accused of Misleading Investors on COVI
Post# of 11802
(Total Views: 600)
Posted On: 07/21/2021 12:14:27 PM
CEO, CTO Accused of Misleading Investors on COVID-19 Test
https://www.ai-cio.com/news/ceo-cto-accused-o...d-19-test/
Quote:
Without admitting or denying the SEC’s charges, Parallax, Arena, and Bradley consented to pay penalties of $100,000, $45,000, and $40,000, respectively.
$100.000 would be the equivalent of 12.000 sold genviro kits...
(2)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼